INS and type 1 diabetes mellitus: Although, ostensibly contrary to a study by Cherubini et al.,18 which concluded that simultaneous use of RT‐CGM+CSII was associated with a higher percentage of TIR, lower time above range >180 mg/dl and lower HbA1c, it was rather a cross‐sectional study on children <18 years old with type 1 diabetes and it did not assess TIR change from baseline but compared results to other insulin delivery and CGM modalities (isCGM+MDI, RT‐CGM+MDI, isCGM+CSII, and RT‐CGM+CSII).